The acquisition reflects Cardinal’s expanded focus on urology in pursuit of higher growth margin versus drug distribution.

Recent acquisitions helped to slightly lift the healthcare-products distributor’s profit and revenue, as the company faces lingering malaise stemming from its OptumRx contract expiration.

Cardinal Health's Specialty Alliance will acquire Solaris Health for $1.9 billion, enhancing its urology capabilities. The acquisition aligns with Cardinal's strategic focus on specialty growth and is expected to close by the end of 2025.